Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -100.00% | -78.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -100.00% | -78.05% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -100.00% | -78.05% |
| SG&A Expenses | -5.48% | -3.87% | -3.48% | 0.56% | 0.28% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.53% | -3.14% | -3.57% | 0.97% | 0.42% |
| Operating Income | 4.34% | -3.96% | -3.53% | -8.52% | -5.15% |
| Income Before Tax | 5.38% | 54.97% | 57.33% | 44.81% | 67.68% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 5.38% | 54.97% | 57.33% | 44.81% | 67.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.38% | 54.97% | 57.33% | 44.81% | 67.68% |
| EBIT | 4.34% | -3.96% | -3.53% | -8.52% | -5.15% |
| EBITDA | 4.10% | -4.27% | -3.82% | -8.68% | -5.34% |
| EPS Basic | 0.00% | 53.33% | 55.10% | 44.19% | 68.25% |
| Normalized Basic EPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS Diluted | 0.00% | 53.33% | 55.10% | 61.90% | 75.90% |
| Normalized Diluted EPS | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
